Delivery Order SPE2DE21D0005-SPE2D624F30MX

Award Date 1/25/24
Potential Completion Date 1/31/24
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company, to provide PURAPLY AM wound dressings. The order is part of a larger $49.5 million multiple-award indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials through May 2026. Organogenesis also maintains Blanket Purchase Agreements valued up to $7 million...
This is a $1,678.32 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is for the supply of PURAPLY AM (2x2) 4 sq cm wound care dressings, with a period of performance through June 4, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $49.5 million multiple-award IDC with the DLA for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,500.00 fixed-price delivery order is for the procurement of medical supplies, specifically PURAPLY AM XT 4.91X4.91 wound dressings. The contract has a period of performance through July 23, 2024. Organogenesis is a long-standing federal contractor that specializes in the development and manufacture of advanced wound care and...
This is a $8,800.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a manufacturer of regenerative medicine products. The contract is for the delivery of PURAPLY AM XT wound care dressings and has a completion date of June 25, 2024. Organogenesis Inc. is a leading provider of advanced wound care and surgical biologics to the federal government, particularly the Department of Defense (DoD) and Department of Veterans...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,800.00 contract is for the supply of PURAPLY AM XT wound care dressings. This order is part of a larger $183.15 million Multiple Award Indefinite Delivery Contract (IDC) issued by the DLA for medical and surgical supplies under the Medical/Surgical ECAT Program. Organogenesis also holds other significant IDVs with the...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products headquartered in Canton, Massachusetts. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and has a period of performance through March 6, 2025. This award is not associated with a set-aside designation,...
This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D624F30MX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company, for the supply of PURAPLY AM wound dressings. The contract has a potential value of $1,118.88 and is a fixed-price with economic price adjustment contract type. The period of performance is from the award date of January 25, 2024 through January 31, 2024. This award is not associated with a set-aside designation.

Organogenesis Inc. has a history of supplying wound care dressings, surgical implants, tissue regeneration products, and other medical supplies to various federal agencies, including the Department of Defense and Department of Veterans Affairs, through a range of indefinite delivery contracts and Federal Supply Schedule agreements. The company currently holds several key federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract with the VA for next-generation surgical implants, a $30 million multiple-award Federal Supply Schedule to supply tissue regeneration products for wound and tissue repair, and a $49.5 million multiple-award Indefinite Delivery Contract with the Defense Logistics Agency for wound care dressings, discs, and medical materials.

Generated 4/25/24, 6:30 PM